CTAS
27
3
FOX
26
-2
YUM
58
2
PSA
35
15
HPE
63
4
VTR
63
6
BMY
66
-3
ETN
55
-2
AMZN
42
-2
PNC
59
3
PEG
36
2
GLW
82
3
AMGN
39
-5
L
67
3
ADP
39
3
PFE
45
-15
AES
46
2
URBN
54
4
SRE
68
2
SPG
30
3
CTAS
27
3
FOX
26
-2
YUM
58
2
PSA
35
15
HPE
63
4
VTR
63
6
BMY
66
-3
ETN
55
-2
AMZN
42
-2
PNC
59
3
PEG
36
2
GLW
82
3
AMGN
39
-5
L
67
3
ADP
39
3
PFE
45
-15
AES
46
2
URBN
54
4
SRE
68
2
SPG
30
3
Financhill
Back

State Street SPDR Portfolio S&P Sctr Neutrl Dv ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
47

SPDG
State Street SPDR Portfolio S&P Sctr Neutrl Dv ETF

Last Price:
$41.64
Seasonality Move:
-1.18%
Buy
100

ORKA
Oruka Therapeutics, Inc.

Last Price:
$53.39
Seasonality Move:
5.42%
Sell
47
State Street SPDR Portfolio S&P Sctr Neutrl Dv ETF (SPDG) is a Sell

Is State Street SPDR Portfolio S&P Sctr Neutrl Dv ETF a Buy, Sell or Hold?

  • The current State Street SPDR Portfolio S&P Sctr Neutrl Dv ETF [SPDG] share price is $41.78. The Score for SPDG is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • SPDG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

SPDG Stock Price Chart

What is State Street SPDR Portfolio S&P Sctr Neutrl Dv ETF's stock price today?

  • The State Street SPDR Portfolio S&P Sctr Neutrl Dv ETF share price today is $41.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPDG is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $53.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

SPDG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.91 Buy
Relative Strength Index (14 RSI): 43.4 Sell
Chaikin Money Flow: 1484 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.38 - 43.3) Sell
Bollinger Bands (100): (40.6 - 43.52) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 77.59 Buy
Chaikin Money Flow: 1458349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 45.6) Buy
Bollinger Bands (100): (27.9 - 38.44) Buy

SPDG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.57 Buy
20-day SMA: 41.93 Sell
50-day SMA: 43.1 Sell
200-day SMA: 40.74 Buy
8-day EMA: 39.54 Buy
20-day EMA: 29.05 Buy
50-day EMA: 15.84 Buy
200-day EMA: 4.7 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Buy
20-day SMA: 41.09 Buy
50-day SMA: 36.64 Buy
200-day SMA: 25.3 Buy
8-day EMA: 47.34 Buy
20-day EMA: 42.69 Buy
50-day EMA: 37.82 Buy
200-day EMA: 28.4 Buy

State Street SPDR Portfolio S&P Sctr Neutrl Dv ETF Earnings Growth & SPDG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.

State Street SPDR Portfolio S&P Sctr Neutrl Dv ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):